ID   ADT1_HUMAN              Reviewed;         298 AA.
AC   P12235; D3DP59;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   10-MAY-2017, entry version 200.
DE   RecName: Full=ADP/ATP translocase 1;
DE   AltName: Full=ADP,ATP carrier protein 1;
DE   AltName: Full=ADP,ATP carrier protein, heart/skeletal muscle isoform T1;
DE   AltName: Full=Adenine nucleotide translocator 1;
DE            Short=ANT 1;
DE   AltName: Full=Solute carrier family 25 member 4;
GN   Name=SLC25A4; Synonyms=ANT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2823266; DOI=10.1073/pnas.84.21.7580;
RA   Neckelmann N., Li K., Wade R.P., Shuster R., Wallace D.C.;
RT   "cDNA sequence of a human skeletal muscle ADP/ATP translocator: lack
RT   of a leader peptide, divergence from a fibroblast translocator cDNA,
RT   and coevolution with mitochondrial DNA genes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:7580-7584(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2541251; DOI=10.1016/0022-2836(89)90477-4;
RA   Cozens A.L., Runswick M.J., Walker J.E.;
RT   "DNA sequences of two expressed nuclear genes for human mitochondrial
RT   ADP/ATP translocase.";
RL   J. Mol. Biol. 206:261-280(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2547778;
RA   Li K., Warner C.K., Hodge J.A., Minoshima S., Kudoh J., Fukuyama R.,
RA   Maekawa M., Shimizu Y., Shimizu N., Wallace D.C.;
RT   "A human muscle adenine nucleotide translocator gene has four exons,
RT   is located on chromosome 4, and is differentially expressed.";
RL   J. Biol. Chem. 264:13998-14004(1989).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=20843780; DOI=10.1093/nar/gkq750;
RA   Wang W., Shen P., Thiyagarajan S., Lin S., Palm C., Horvath R.,
RA   Klopstock T., Cutler D., Pique L., Schrijver I., Davis R.W.,
RA   Mindrinos M., Speed T.P., Scharfe C.;
RT   "Identification of rare DNA variants in mitochondrial disorders with
RT   improved array-based sequencing.";
RL   Nucleic Acids Res. 39:44-58(2011).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye, Mammary gland, and PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-37.
RC   TISSUE=Liver;
RX   PubMed=2829183; DOI=10.1073/pnas.85.2.377;
RA   Houldsworth J., Attardi G.;
RT   "Two distinct genes for ADP/ATP translocase are expressed at the mRNA
RT   level in adult human liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:377-381(1988).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-31; 34-43; 64-92; 141-147; 189-199 AND 273-296,
RP   CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT GLY-2, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma;
RA   Bienvenut W.V.;
RL   Submitted (OCT-2004) to UniProtKB.
RN   [9]
RP   INTERACTION WITH HIV-1 VPR.
RX   PubMed=16120388; DOI=10.1016/j.mito.2004.06.012;
RA   Deniaud A., Brenner C., Kroemer G.;
RT   "Mitochondrial membrane permeabilization by HIV-1 Vpr.";
RL   Mitochondrion 4:223-233(2004).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   INVOLVEMENT IN MTDPS12B.
RX   PubMed=22187496; DOI=10.1136/jmedgenet-2011-100504;
RA   Echaniz-Laguna A., Chassagne M., Ceresuela J., Rouvet I., Padet S.,
RA   Acquaviva C., Nataf S., Vinzio S., Bozon D., Mousson de Camaret B.;
RT   "Complete loss of expression of the ANT1 gene causing cardiomyopathy
RT   and myopathy.";
RL   J. Med. Genet. 49:146-150(2012).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [14]
RP   FUNCTION, INVOLVEMENT IN MTDPS12A, VARIANTS MTDPS12A HIS-80 AND
RP   GLY-235, CHARACTERIZATION OF VARIANTS MTDPS12A HIS-80 AND GLY-235,
RP   CHARACTERIZATION OF VARIANTS PEOA2 ASP-90; PRO-98; GLY-104 AND
RP   PRO-114, AND CHARACTERIZATION OF VARIANTS MTDPS12B ASP-123 AND
RP   PRO-236.
RX   PubMed=27693233; DOI=10.1016/j.ajhg.2016.08.014;
RA   Thompson K., Majd H., Dallabona C., Reinson K., King M.S.,
RA   Alston C.L., He L., Lodi T., Jones S.A., Fattal-Valevski A.,
RA   Fraenkel N.D., Saada A., Haham A., Isohanni P., Vara R., Barbosa I.A.,
RA   Simpson M.A., Deshpande C., Puusepp S., Bonnen P.E., Rodenburg R.J.,
RA   Suomalainen A., Ounap K., Elpeleg O., Ferrero I., McFarland R.,
RA   Kunji E.R., Taylor R.W.;
RT   "Recurrent de novo dominant mutations in SLC25A4 cause severe early-
RT   onset mitochondrial disease and loss of mitochondrial DNA copy
RT   number.";
RL   Am. J. Hum. Genet. 99:860-876(2016).
RN   [15]
RP   VARIANTS PEOA2 PRO-114 AND MET-289.
RX   PubMed=10926541; DOI=10.1126/science.289.5480.782;
RA   Kaukonen J., Juselius J.K., Tiranti V., Kyttala A., Zeviani M.,
RA   Comi G.P., Keranen J., Peltonen L., Suomalainen A.;
RT   "Role of adenine nucleotide translocator 1 in mtDNA maintenance.";
RL   Science 289:782-785(2000).
RN   [16]
RP   VARIANT PEOA2 PRO-98.
RX   PubMed=11756613; DOI=10.1212/WNL.57.12.2295;
RA   Napoli L., Bordoni A., Zeviani M., Hadjigeorgiou G.M., Sciacco M.,
RA   Tiranti V., Terentiou A., Moggio M., Papadimitriou A., Scarlato G.,
RA   Comi G.P.;
RT   "A novel missense adenine nucleotide translocator-1 gene mutation in a
RT   Greek adPEO family.";
RL   Neurology 57:2295-2298(2001).
RN   [17]
RP   VARIANT PEOA2 GLY-104.
RX   PubMed=12112115; DOI=10.1002/ana.10172;
RA   Komaki H., Fukazawa T., Houzen H., Yoshida K., Nonaka I., Goto Y.;
RT   "A novel D104G mutation in the adenine nucleotide translocator 1 gene
RT   in autosomal dominant progressive external ophthalmoplegia patients
RT   with mitochondrial DNA with multiple deletions.";
RL   Ann. Neurol. 51:645-648(2002).
RN   [18]
RP   VARIANT PEOA2 MET-289.
RX   PubMed=12707443; DOI=10.1212/01.WNL.0000056088.09408.3C;
RA   Agostino A., Valletta L., Chinnery P.F., Ferrari G., Carrara F.,
RA   Taylor R.W., Schaefer A.M., Turnbull D.M., Tiranti V., Zeviani M.;
RT   "Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive
RT   external ophthalmoplegia (PEO).";
RL   Neurology 60:1354-1356(2003).
RN   [19]
RP   VARIANT MTDPS12B ASP-123.
RX   PubMed=16155110; DOI=10.1093/hmg/ddi341;
RA   Palmieri L., Alberio S., Pisano I., Lodi T., Meznaric-Petrusa M.,
RA   Zidar J., Santoro A., Scarcia P., Fontanesi F., Lamantea E.,
RA   Ferrero I., Zeviani M.;
RT   "Complete loss-of-function of the heart/muscle-specific adenine
RT   nucleotide translocator is associated with mitochondrial myopathy and
RT   cardiomyopathy.";
RL   Hum. Mol. Genet. 14:3079-3088(2005).
RN   [20]
RP   VARIANT PEOA2 ASP-90.
RX   PubMed=15792871; DOI=10.1016/j.nmd.2004.12.004;
RA   Deschauer M., Hudson G., Mueller T., Taylor R.W., Chinnery P.F.,
RA   Zierz S.;
RT   "A novel ANT1 gene mutation with probable germline mosaicism in
RT   autosomal dominant progressive external ophthalmoplegia.";
RL   Neuromuscul. Disord. 15:311-315(2005).
RN   [21]
RP   VARIANTS PEOA2 PRO-98 AND PRO-114.
RX   PubMed=18575922; DOI=10.1007/s00415-008-0926-3;
RA   Virgilio R., Ronchi D., Hadjigeorgiou G.M., Bordoni A., Saladino F.,
RA   Moggio M., Adobbati L., Kafetsouli D., Tsironi E., Previtali S.,
RA   Papadimitriou A., Bresolin N., Comi G.P.;
RT   "Novel Twinkle (PEO1) gene mutations in Mendelian progressive external
RT   ophthalmoplegia.";
RL   J. Neurol. 255:1384-1391(2008).
RN   [22]
RP   VARIANT MTDPS12B PRO-236.
RX   PubMed=25732997; DOI=10.1007/8904_2015_409;
RA   Koerver-Keularts I.M., de Visser M., Bakker H.D., Wanders R.J.,
RA   Vansenne F., Scholte H.R., Dorland L., Nicolaes G.A., Spaapen L.M.,
RA   Smeets H.J., Hendrickx A.T., van den Bosch B.J.;
RT   "Two novel mutations in the SLC25A4 gene in a patient with
RT   mitochondrial myopathy.";
RL   JIMD Rep. 22:39-45(2015).
CC   -!- FUNCTION: Involved in mitochondrial ADP/ATP transport. Catalyzes
CC       the exchange of cytoplasmic ADP with mitochondrial ATP across the
CC       mitochondrial inner membrane. {ECO:0000269|PubMed:27693233}.
CC   -!- SUBUNIT: Found in a complex with ARL2, ARL2BP and SLC25A4.
CC       Interacts with ARL2BP (By similarity). Homodimer. Interacts with
CC       HIV-1 Vpr. {ECO:0000250, ECO:0000269|PubMed:16120388}.
CC   -!- INTERACTION:
CC       Q5S007:LRRK2; NbExp=2; IntAct=EBI-359074, EBI-5323863;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane; Multi-pass
CC       membrane protein.
CC   -!- DISEASE: Progressive external ophthalmoplegia with mitochondrial
CC       DNA deletions, autosomal dominant, 2 (PEOA2) [MIM:609283]: A
CC       disorder characterized by progressive weakness of ocular muscles
CC       and levator muscle of the upper eyelid. In a minority of cases, it
CC       is associated with skeletal myopathy, which predominantly involves
CC       axial or proximal muscles and which causes abnormal fatigability
CC       and even permanent muscle weakness. Ragged-red fibers and atrophy
CC       are found on muscle biopsy. A large proportion of chronic
CC       ophthalmoplegias are associated with other symptoms, leading to a
CC       multisystemic pattern of this disease. Additional symptoms are
CC       variable, and may include cataracts, hearing loss, sensory axonal
CC       neuropathy, ataxia, depression, hypogonadism, and parkinsonism.
CC       {ECO:0000269|PubMed:10926541, ECO:0000269|PubMed:11756613,
CC       ECO:0000269|PubMed:12112115, ECO:0000269|PubMed:12707443,
CC       ECO:0000269|PubMed:15792871, ECO:0000269|PubMed:18575922,
CC       ECO:0000269|PubMed:27693233}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Mitochondrial DNA depletion syndrome 12B, cardiomyopathic
CC       type (MTDPS12B) [MIM:615418]: An autosomal recessive mitochondrial
CC       disorder characterized by childhood onset of slowly progressive
CC       hypertrophic cardiomyopathy and generalized skeletal myopathy
CC       resulting in exercise intolerance and, in some patients, muscle
CC       weakness and atrophy. Skeletal muscle biopsy shows ragged red
CC       fibers, mtDNA depletion, and accumulation of abnormal
CC       mitochondria. {ECO:0000269|PubMed:16155110,
CC       ECO:0000269|PubMed:22187496, ECO:0000269|PubMed:25732997,
CC       ECO:0000269|PubMed:27693233}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Mitochondrial DNA depletion syndrome 12A, cardiomyopathic
CC       type (MTDPS12A) [MIM:617184]: An autosomal dominant mitochondrial
CC       disorder characterized by severe hypotonia due to mitochondrial
CC       dysfunction apparent at birth. Affected infants have respiratory
CC       insufficiency requiring mechanical ventilation and have poor or no
CC       motor development. Many die in infancy, and those that survive
CC       have profound hypotonia with significant muscle weakness and
CC       inability to walk independently. Some patients develop
CC       hypertrophic cardiomyopathy. Muscle samples show mtDNA depletion
CC       and severe combined mitochondrial respiratory chain deficiencies.
CC       {ECO:0000269|PubMed:27693233}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: The transmembrane helices are not perpendicular to
CC       the plane of the membrane, but cross the membrane at an angle.
CC       Odd-numbered transmembrane helices exhibit a sharp kink, due to
CC       the presence of a conserved proline residue (By similarity).
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the mitochondrial carrier (TC 2.A.29)
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J02966; AAA61223.1; -; mRNA.
DR   EMBL; J04982; AAA51736.1; -; Genomic_DNA.
DR   EMBL; HQ206346; ADP92294.1; -; Genomic_DNA.
DR   EMBL; HQ206347; ADP92295.1; -; Genomic_DNA.
DR   EMBL; HQ206348; ADP92296.1; -; Genomic_DNA.
DR   EMBL; HQ206349; ADP92297.1; -; Genomic_DNA.
DR   EMBL; HQ206350; ADP92298.1; -; Genomic_DNA.
DR   EMBL; HQ206351; ADP92299.1; -; Genomic_DNA.
DR   EMBL; HQ206352; ADP92300.1; -; Genomic_DNA.
DR   EMBL; HQ206353; ADP92301.1; -; Genomic_DNA.
DR   EMBL; HQ206354; ADP92302.1; -; Genomic_DNA.
DR   EMBL; HQ206355; ADP92303.1; -; Genomic_DNA.
DR   EMBL; HQ206356; ADP92304.1; -; Genomic_DNA.
DR   EMBL; HQ206357; ADP92305.1; -; Genomic_DNA.
DR   EMBL; HQ206358; ADP92306.1; -; Genomic_DNA.
DR   EMBL; HQ206359; ADP92307.1; -; Genomic_DNA.
DR   EMBL; HQ206360; ADP92308.1; -; Genomic_DNA.
DR   EMBL; HQ206361; ADP92309.1; -; Genomic_DNA.
DR   EMBL; HQ206362; ADP92310.1; -; Genomic_DNA.
DR   EMBL; HQ206363; ADP92311.1; -; Genomic_DNA.
DR   EMBL; HQ206364; ADP92312.1; -; Genomic_DNA.
DR   EMBL; HQ206365; ADP92313.1; -; Genomic_DNA.
DR   EMBL; HQ206366; ADP92314.1; -; Genomic_DNA.
DR   EMBL; HQ206367; ADP92315.1; -; Genomic_DNA.
DR   EMBL; HQ206368; ADP92316.1; -; Genomic_DNA.
DR   EMBL; HQ206369; ADP92317.1; -; Genomic_DNA.
DR   EMBL; HQ206370; ADP92318.1; -; Genomic_DNA.
DR   EMBL; HQ206371; ADP92319.1; -; Genomic_DNA.
DR   EMBL; HQ206372; ADP92320.1; -; Genomic_DNA.
DR   EMBL; HQ206373; ADP92321.1; -; Genomic_DNA.
DR   EMBL; HQ206374; ADP92322.1; -; Genomic_DNA.
DR   EMBL; HQ206375; ADP92323.1; -; Genomic_DNA.
DR   EMBL; HQ206376; ADP92324.1; -; Genomic_DNA.
DR   EMBL; HQ206377; ADP92325.1; -; Genomic_DNA.
DR   EMBL; HQ206378; ADP92326.1; -; Genomic_DNA.
DR   EMBL; HQ206379; ADP92327.1; -; Genomic_DNA.
DR   EMBL; HQ206380; ADP92328.1; -; Genomic_DNA.
DR   EMBL; HQ206381; ADP92329.1; -; Genomic_DNA.
DR   EMBL; HQ206382; ADP92330.1; -; Genomic_DNA.
DR   EMBL; HQ206383; ADP92331.1; -; Genomic_DNA.
DR   EMBL; HQ206384; ADP92332.1; -; Genomic_DNA.
DR   EMBL; HQ206385; ADP92333.1; -; Genomic_DNA.
DR   EMBL; CH471056; EAX04655.1; -; Genomic_DNA.
DR   EMBL; CH471056; EAX04656.1; -; Genomic_DNA.
DR   EMBL; BC008664; AAH08664.1; -; mRNA.
DR   EMBL; BC061589; AAH61589.1; -; mRNA.
DR   EMBL; BC063643; AAH63643.1; -; mRNA.
DR   EMBL; J03593; AAA36751.1; -; mRNA.
DR   CCDS; CCDS34114.1; -.
DR   PIR; A44778; A44778.
DR   RefSeq; NP_001142.2; NM_001151.3.
DR   UniGene; Hs.246506; -.
DR   ProteinModelPortal; P12235; -.
DR   SMR; P12235; -.
DR   BioGrid; 106788; 42.
DR   DIP; DIP-33116N; -.
DR   IntAct; P12235; 20.
DR   MINT; MINT-196037; -.
DR   STRING; 9606.ENSP00000281456; -.
DR   DrugBank; DB01736; [3-(Dodecanoylamino)Propyl](Hydroxy)Dimethylammonium.
DR   DrugBank; DB00171; Adenosine triphosphate.
DR   DrugBank; DB02426; Carboxyatractyloside.
DR   DrugBank; DB03429; Cardiolipin.
DR   DrugBank; DB00720; Clodronate.
DR   DrugBank; DB04178; Di-Stearoyl-3-Sn-Phosphatidylcholine.
DR   TCDB; 2.A.29.1.2; the mitochondrial carrier (mc) family.
DR   iPTMnet; P12235; -.
DR   PhosphoSitePlus; P12235; -.
DR   SwissPalm; P12235; -.
DR   BioMuta; SLC25A4; -.
DR   DMDM; 113455; -.
DR   EPD; P12235; -.
DR   MaxQB; P12235; -.
DR   PaxDb; P12235; -.
DR   PeptideAtlas; P12235; -.
DR   PRIDE; P12235; -.
DR   TopDownProteomics; P12235; -.
DR   DNASU; 291; -.
DR   Ensembl; ENST00000281456; ENSP00000281456; ENSG00000151729.
DR   GeneID; 291; -.
DR   KEGG; hsa:291; -.
DR   UCSC; uc003ixd.4; human.
DR   CTD; 291; -.
DR   DisGeNET; 291; -.
DR   GeneCards; SLC25A4; -.
DR   HGNC; HGNC:10990; SLC25A4.
DR   HPA; HPA046835; -.
DR   HPA; HPA071684; -.
DR   MalaCards; SLC25A4; -.
DR   MIM; 103220; gene.
DR   MIM; 609283; phenotype.
DR   MIM; 615418; phenotype.
DR   MIM; 617184; phenotype.
DR   neXtProt; NX_P12235; -.
DR   OpenTargets; ENSG00000151729; -.
DR   Orphanet; 254892; Autosomal dominant progressive external ophthalmoplegia.
DR   Orphanet; 1369; Congenital cataract - hypertrophic cardiomyopathy - mitochondrial myopathy.
DR   Orphanet; 155; Familial isolated hypertrophic cardiomyopathy.
DR   PharmGKB; PA35866; -.
DR   eggNOG; KOG0749; Eukaryota.
DR   eggNOG; ENOG410XNW0; LUCA.
DR   GeneTree; ENSGT00390000011543; -.
DR   HOGENOM; HOG000165727; -.
DR   HOVERGEN; HBG108348; -.
DR   InParanoid; P12235; -.
DR   KO; K05863; -.
DR   OMA; GSSQREF; -.
DR   OrthoDB; EOG091G0ULB; -.
DR   PhylomeDB; P12235; -.
DR   TreeFam; TF300743; -.
DR   Reactome; R-HSA-1268020; Mitochondrial protein import.
DR   Reactome; R-HSA-180897; Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization.
DR   Reactome; R-HSA-422356; Regulation of insulin secretion.
DR   ChiTaRS; SLC25A4; human.
DR   GeneWiki; SLC25A4; -.
DR   GenomeRNAi; 291; -.
DR   PRO; PR:P12235; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000151729; -.
DR   CleanEx; HS_SLC25A4; -.
DR   ExpressionAtlas; P12235; baseline and differential.
DR   Genevisible; P12235; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005743; C:mitochondrial inner membrane; IBA:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0015207; F:adenine transmembrane transporter activity; TAS:ProtInc.
DR   GO; GO:0005471; F:ATP:ADP antiporter activity; IBA:GO_Central.
DR   GO; GO:0015866; P:ADP transport; IMP:UniProtKB.
DR   GO; GO:0008637; P:apoptotic mitochondrial changes; IEA:Ensembl.
DR   GO; GO:0006091; P:generation of precursor metabolites and energy; TAS:ProtInc.
DR   GO; GO:0000002; P:mitochondrial genome maintenance; TAS:ProtInc.
DR   GO; GO:0060546; P:negative regulation of necroptotic process; IMP:BHF-UCL.
DR   GO; GO:0050796; P:regulation of insulin secretion; TAS:Reactome.
DR   GO; GO:0046902; P:regulation of mitochondrial membrane permeability; IBA:GO_Central.
DR   GO; GO:0006810; P:transport; TAS:ProtInc.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 1.50.40.10; -; 1.
DR   InterPro; IPR002113; Aden_trnslctor.
DR   InterPro; IPR002067; Mit_carrier.
DR   InterPro; IPR018108; Mitochondrial_sb/sol_carrier.
DR   InterPro; IPR023395; Mt_carrier_dom.
DR   Pfam; PF00153; Mito_carr; 3.
DR   PRINTS; PR00927; ADPTRNSLCASE.
DR   PRINTS; PR00926; MITOCARRIER.
DR   SUPFAM; SSF103506; SSF103506; 1.
DR   PROSITE; PS50920; SOLCAR; 3.
PE   1: Evidence at protein level;
KW   Acetylation; Cardiomyopathy; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Host-virus interaction;
KW   Membrane; Mitochondrion; Mitochondrion inner membrane;
KW   Progressive external ophthalmoplegia; Reference proteome; Repeat;
KW   S-nitrosylation; Transmembrane; Transmembrane helix; Transport.
FT   INIT_MET      1      1       Removed. {ECO:0000269|Ref.8}.
FT   CHAIN         2    298       ADP/ATP translocase 1.
FT                                /FTId=PRO_0000090574.
FT   TRANSMEM      5     39       Helical; Name=1. {ECO:0000250}.
FT   TRANSMEM     75    100       Helical; Name=2. {ECO:0000250}.
FT   TRANSMEM    109    143       Helical; Name=3. {ECO:0000250}.
FT   TRANSMEM    176    202       Helical; Name=4. {ECO:0000250}.
FT   TRANSMEM    207    241       Helical; Name=5. {ECO:0000250}.
FT   TRANSMEM    273    298       Helical; Name=6. {ECO:0000250}.
FT   REPEAT        6     98       Solcar 1.
FT   REPEAT      111    201       Solcar 2.
FT   REPEAT      212    297       Solcar 3.
FT   MOTIF       235    240       Substrate recognition. {ECO:0000250}.
FT   BINDING      80     80       Nucleotide. {ECO:0000250}.
FT   MOD_RES       2      2       N-acetylglycine. {ECO:0000269|Ref.8}.
FT   MOD_RES     147    147       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P48962}.
FT   MOD_RES     160    160       S-nitrosocysteine.
FT                                {ECO:0000250|UniProtKB:Q05962}.
FT   MOD_RES     245    245       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P48962}.
FT   MOD_RES     272    272       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P48962}.
FT   VARIANT      80     80       R -> H (in MTDPS12A; decreased function
FT                                in ADP transport).
FT                                {ECO:0000269|PubMed:27693233}.
FT                                /FTId=VAR_078071.
FT   VARIANT      90     90       A -> D (in PEOA2; decreased function in
FT                                ADP transport).
FT                                {ECO:0000269|PubMed:15792871,
FT                                ECO:0000269|PubMed:27693233}.
FT                                /FTId=VAR_038814.
FT   VARIANT      98     98       L -> P (in PEOA2; decreased function in
FT                                ADP transport; dbSNP:rs104893876).
FT                                {ECO:0000269|PubMed:11756613,
FT                                ECO:0000269|PubMed:18575922,
FT                                ECO:0000269|PubMed:27693233}.
FT                                /FTId=VAR_022459.
FT   VARIANT     104    104       D -> G (in PEOA2; decreased function in
FT                                ADP transport; dbSNP:rs28999114).
FT                                {ECO:0000269|PubMed:12112115,
FT                                ECO:0000269|PubMed:27693233}.
FT                                /FTId=VAR_022460.
FT   VARIANT     114    114       A -> P (in PEOA2; decreased function in
FT                                ADP transport; dbSNP:rs104893873).
FT                                {ECO:0000269|PubMed:10926541,
FT                                ECO:0000269|PubMed:18575922,
FT                                ECO:0000269|PubMed:27693233}.
FT                                /FTId=VAR_012111.
FT   VARIANT     123    123       A -> D (in MTDPS12B; loss of function in
FT                                ADP transport; dbSNP:rs121912683).
FT                                {ECO:0000269|PubMed:16155110,
FT                                ECO:0000269|PubMed:27693233}.
FT                                /FTId=VAR_038815.
FT   VARIANT     235    235       R -> G (in MTDPS12A; severely decreased
FT                                function in ADP transport).
FT                                {ECO:0000269|PubMed:27693233}.
FT                                /FTId=VAR_078072.
FT   VARIANT     236    236       R -> P (in MTDPS12B; loss of function in
FT                                ADP transport).
FT                                {ECO:0000269|PubMed:25732997,
FT                                ECO:0000269|PubMed:27693233}.
FT                                /FTId=VAR_078073.
FT   VARIANT     289    289       V -> M (in PEOA2; dbSNP:rs104893874).
FT                                {ECO:0000269|PubMed:10926541,
FT                                ECO:0000269|PubMed:12707443}.
FT                                /FTId=VAR_012112.
FT   CONFLICT     16     16       G -> A (in Ref. 1; AAA61223).
FT                                {ECO:0000305}.
FT   CONFLICT    147    149       KGA -> RR (in Ref. 1; AAA61223).
FT                                {ECO:0000305}.
FT   CONFLICT    227    227       V -> L (in Ref. 1; AAA61223).
FT                                {ECO:0000305}.
SQ   SEQUENCE   298 AA;  33064 MW;  59F0DFAEC4E7CFBB CRC64;
     MGDHAWSFLK DFLAGGVAAA VSKTAVAPIE RVKLLLQVQH ASKQISAEKQ YKGIIDCVVR
     IPKEQGFLSF WRGNLANVIR YFPTQALNFA FKDKYKQLFL GGVDRHKQFW RYFAGNLASG
     GAAGATSLCF VYPLDFARTR LAADVGKGAA QREFHGLGDC IIKIFKSDGL RGLYQGFNVS
     VQGIIIYRAA YFGVYDTAKG MLPDPKNVHI FVSWMIAQSV TAVAGLVSYP FDTVRRRMMM
     QSGRKGADIM YTGTVDCWRK IAKDEGAKAF FKGAWSNVLR GMGGAFVLVL YDEIKKYV
//
